Once weve got your levels back up, youll shift to a maintenance dose
Information provided is for educational purposes only and has not been evaluated by the FDA
AOD-9604 doesn't bind to the growth hormone receptor, so it doesn't raise IGF-1, doesn't disrupt blood sugar, and doesn't carry the side effects of full hGH like fluid retention or carpal tunnel symptoms
AOD 9604 Studies on Obesity Models In obese murine models, both growth hormone and AOD 9604 have been linked to reductions in body fat mass, though the outcomes appeared different in lean models
While Semaglutide (Ozempic, Wegovy) targets one receptor and Tirzepatide (Mounjaro, Zepbound) targets two, Retatrutide activates three distinct metabolic receptors simultaneously
0.2 mL delivers the 3 mg target